Home›People›Hangjun Zhan
Hangjun Zhan

Hangjun Zhan

Director at Vetmab Biosciences.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Sep 29, 2026·Suggest an edit

About Hangjun Zhan

Hangjun Zhan is a director at Vetmab Biosciences.

Hangjun Zhan reports to the SEC as an officer of 1 public company: Kindred Biosciences (KIN).

Hangjun Zhan first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Hangjun Zhan in the role, so the role may have started earlier or lasted longer.

Vetmab Biosciences, Inc.
Director
2022 – 2026 · San Diego, CA
Develops antibody treatments for veterinarians caring for dogs and cats.
Kindred Biosciences, Inc.
Chief Scientific Officer
2018 – 2021 · Public company (KIN)

Key Colleagues at Startups

The people Hangjun Zhan works with at each company, as listed on that company's latest Form D.

Vetmab Biosciences, Inc. · Form D, Sep 29, 2026
Denise Bevers
Denise Bevers
Co-founder, President & CEO, Board Member
Richard Chin
Richard Chin
Co-founder, Chair of the Board
NA
CM
Chrysa Mineo
Director

Sources

  1. SECVetmab Biosciences, Inc. Form D, filed Sep 29, 2026
  2. SECForms 3, 4 and 5 filed by Hangjun Zhan (SEC filer 1719057)